Buzz
We all dream of being part of a generation that uncovers groundbreaking cures for diseases, particularly those that have claimed so many lives. Over the past few years, remarkable medical advancements have emerged, though some of these milestones might have gone unnoticed in times when good news was scarce. Around the globe, scientists are tirelessly working to discover cures and expand our understanding of long-standing ailments.
From finding potential cures for cancer and neurological disorders to growing human organs in laboratories and successfully transplanting them, the list of breakthroughs is extensive, though by no means complete. The next frontier in medical miracles is bound to be artificial intelligence. Trust us on this one, folks!
10. Neurodegenerative Diseases May Soon Be Manageable
In February 2022, the Halberd Corporation, based in Pennsylvania, achieved a major breakthrough in the treatment of neurodegenerative diseases. By removing glutamate from cerebrospinal fluid, they demonstrated the potential to control disease-related antigens in the ten most prominent diseases within this medical field. Some of the diseases this discovery could affect include PTSD (post-traumatic stress disorder), traumatic brain injury, chronic traumatic encephalopathy, Alzheimer’s disease, Parkinson’s disease, epilepsy, and other neurodegenerative conditions.
The methods employed by scientists are ultimately aimed at fostering healthy brain function. William A. Hartman, Halberd’s Chairman, President, and CEO, remarked, “This breakthrough will offer hope to the 36 million Americans each year, along with countless others worldwide, who suffer from various neurodegenerative diseases.”
9. A Promising Cure for Stage IV Melanoma Cancer
In April 2020, researchers at the Melanoma Institute in Australia made significant progress in reducing the mortality rate for stage 4 melanoma, often referred to as “Australia’s cancer.” A stage 4 melanoma diagnosis typically comes with a grim prognosis of six to nine months, but after undergoing immunotherapy at the Melanoma Institute, 50% of patients are surviving long enough to be considered scientifically cured. Immunotherapy harnesses the patient’s own immune system to fight cancer, and has been likened to the groundbreaking discovery of penicillin by Associate Professor Menzies.
In Australia, over 1,700 individuals succumb to melanoma annually. The immunotherapy focuses on three key drugs: Keytruda, Opdivo, and Yervoy. The innovative combination of these treatments has revolutionized the fight against stage IV melanoma. Researchers now aim to determine why 50% of patients do not respond to the therapy and investigate whether this treatment could benefit other types of cancer.
8. TETA Treatment: A Possible Cure for Children’s Cancer
At the Children’s Cancer Institute in New South Wales, Australia, scientists have conducted tests using a treatment known as TETA on mice, reducing tumor size by 40%. This significant shrinkage has resulted in a doubling of the mice’s lifespan, all while utilizing an affordable medication already approved for human use, which is commonly prescribed for Wilson’s disease.
Wilson’s disease causes an accumulation of copper in the liver. The research led by Dr. Vittorio also indicates that this treatment may have potential in combating other cancers such as breast, pancreatic, and lung cancer. The therapy is particularly effective against neuroblastoma, a disease responsible for 15% of all childhood cancer deaths, with a survival rate of 50%. The treatment works by removing copper from the body, enabling the immune system to recognize and fight the tumor.
7. Premature Infants and Chronic Lung Disease
Premature babies suffering from chronic lung disease were treated with the Hobart Method, a less invasive technique for delivering surfactant through a small tube placed in the windpipe to aid their breathing. Developed by Peter Dargaville from the University of Tasmania after extensive trials, this method was used in 33 neonatal units across 11 countries. The results of this work were published in December 2021.
The lung condition they aimed to prevent is called bronchopulmonary dysplasia, which occurs when a newborn’s lungs are underdeveloped in the womb or if premature birth leads to lung inflammation. A follow-up study is being conducted to assess the long-term effects of administering surfactant to these infants.
6. A Vaccine for Brain Tumors Increases Survival by 5 Years
A groundbreaking vaccine for brain tumor patients has shown the ability to double the five-year survival rate, a significant achievement that has been sought for decades. At King’s College Hospital in London, 13% of patients who received the vaccine were still alive after five years, compared to just 5.7% in the control group. This marks the first progress in nearly two decades regarding treatments for aggressive glioblastoma. Even patients with poor prognoses, including older individuals who were not candidates for surgery, experienced extended life expectancy due to the vaccine.
Immunotherapy is utilized in this treatment by enabling the body to recognize and attack cancer cells. Each patient receives a personalized vaccine created by analyzing their immune cells, known as dendritic cells. These cells capture and present the cancer cells, allowing the immune system to target and destroy them.
Once the dendritic cells are extracted from the patient’s body, they are combined with tumor biomarkers. When reinjected into the patient, the cells share critical information with the immune system, triggering an attack on the tumor. The medical team is now exploring the potential to use this vaccine with other types of cancer and different drug combinations.
5. Advancements in Imaging and Sensing Techniques
Circulatory diseases are becoming easier to detect thanks to advanced imaging and sensing techniques. At Coventry University’s Centre of Intelligent Healthcare, researchers are exploring neurovascular imaging, a method that captures detailed images of even the tiniest blood vessels in the body. This research aims to uncover how circulatory systems influence early-stage diseases such as diabetes, autoimmune disorders, cancer, and arterial aging. By using various light colors, they can analyze blood flow, composition, and temperature, providing valuable diagnostic insights. The process is both non-invasive and affordable.
With this technology, the team aims to find new treatment options for Reynaud’s phenomenon, a condition where fingers and toes change color in response to anxiety or cold. Reynaud’s phenomenon can sometimes signal more serious underlying health issues that affect internal organs.
4. Innovative Dressings for Hidradenitis Suppurativa
A former chef has contributed to the development of specialized dressings to help manage the challenging symptoms of hidradenitis suppurativa (HS). Suzanne Moloney, founder of HidraMed Solutions, created adhesive-free dressings that are compatible with a variety of uniquely designed underwear. Her Irish company received the Irish Times Innovation of the Year Award in 2021 for its efforts to support the 4% of the global population affected by HS.
The painful lesions and abscesses caused by HS commonly appear in areas like the armpit, thigh, and groin. These require regular dressing changes that remain in place without leaking, falling off, or shifting. Traditional dressings often use adhesives that can cause more damage than relief when applied or removed, making the process uncomfortable and stressful. People living with HS frequently face risks of social isolation, depression, and anxiety due to the strain of managing the condition. Moloney’s designs feature discreet pads and fastenings, incorporated into stylish items such as crop tops, t-shirts, and boxers.
3. British Army Trials Remote Surgery Technology
The British Army is testing innovative technologies that could enable soldiers injured on the battlefield, even from thousands of miles away, to receive potentially life-saving surgeries through augmented reality glasses. 'Project Lara' explains that in typical combat scenarios, junior medics are deployed closer to the frontline, while senior medics operate from further behind, overseeing a larger area. This means junior medics often need more guidance than their senior counterparts, yet communication tends to be worse the closer you are to the danger zone.
Project Lara’s objective is to provide junior medics with essential information and expert advice when they need it most. Using the Microsoft HoloLens 2 augmented reality glasses, a specialist can assist a medic in the field with routine tasks, monitor surgeries, and provide guidance and instructions when necessary.
2. Two Breakthroughs in HIV Cure Stories
A woman has become the third person ever to be cured of HIV following a stem cell treatment. This groundbreaking case is also the first to utilize umbilical cord blood, potentially making this treatment more accessible in the future. She was originally treated for leukemia in the bone marrow and, after her treatment, has been in remission for 14 months without the need for antiretroviral therapy, which is typically used to manage HIV.
In a groundbreaking 2022 development, a new vaccine has been created to activate the immune system and cure AIDS. Researchers at Tel Aviv University utilized gene editing to design a vaccine capable of neutralizing the HIV virus. The vaccine works by reprogramming B-type white blood cells to stimulate the immune system to produce antibodies that effectively neutralize HIV.
1. First Successful Transplant of a 3D-Printed Lab-Grown Ear
A woman with microtia, a condition where the ear is underdeveloped or absent at birth, has successfully received a 3D-printed ‘living’ ear transplant. The ear was crafted using human skin cells and 3D printing technology in a lab, marking a historic first. Scientists in the U.S. used ear tissue cells from her own ear as ‘bio-ink’ to create the new ear, significantly reducing the chances of her body rejecting its own cells.
Typically, microtia is treated through invasive surgeries involving rib cartilage extraction or implants. This is usually done for children born with the condition. Dr. Bonilla, the lead physician, remarked, 'I am inspired by what this technology may mean for microtia patients and their families.'
